Regulated interactions of the norepineprhine transporter by the actin and microtubule cytoskeletons

Journal of Neurochemistry

Volumn 105, Issue 5, 2008, Pages 1668-1682

  Jeannotte, Alexis M ^b   Sidhu, Anita ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

synuclein; Actin; Depression; Microtubule; Norepinephrine transporter; Parkinson's disease

Indexed keywords

ACTIN; ALPHA SYNUCLEIN; CYTOCHALASIN D; CYTOSKELETON PROTEIN; MICROTUBULE PROTEIN; NORADRENALIN TRANSPORTER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; DEPOLYMERIZATION; DOSE RESPONSE; FRONTAL CORTEX; KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN POLYMERIZATION; RAT;

ACTINS; ALPHA-SYNUCLEIN; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CYTOSKELETON; FEMALE; HUMANS; MALE; MICE; MICROTUBULES; NEURONS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 43549108762     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05258.x     Document Type: Article

References (72)

1. Apparsundaram S., Galli A., DeFelice L. J. et al. (1998) Acute regulation of norepinephrine transport: I. Protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. J. Pharmacol. Exp. Ther. 287, 733 743.
2. Apparsundaram S., Sung U., Price R. D. et al. (2001) Trafficking- dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. J. Pharmacol. Exp. Ther. 299, 666 677.
3. Aston-Jones G. Cohen J. D. (2005) An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. Annu. Rev. Neurosci. 28, 403 450.
4. Aston-Jones G., Rajkowski J. Cohen J. (2000) Locus coeruleus and regulation of behavioral flexibility and attention. Prog. Brain Res. 126, 165 182.
5. Aunis D. Bader M. F. (1988) The cytoskeleton as a barrier to exocytosis in secretory cells. J. Exp. Biol. 139, 253 266.
6. Bauman P. A. Blakely R. D. (2002) Determinants within C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity. Arch. Biochem. Biophys. 404, 80 91.
7. Benmansour S., Altamirano A. V., Jones D. J. et al. (2004) Regulation of the norepinephrine transporter by chronic administration of antidepressants. Biol. Psychiatry 55, 313 316.
8. Bernstein B. W. Bamburg J. R. (1989) Cycling of actin assembly in synaptosomes and neurotransmitter release. Neuron 3, 257 265.
9. Bonisch H. Bruss M. (2006) The norepinephrine transporter in physiology and disease. Handb. Exp. Pharmacol. 175, 485 524.
10. Bussell R., Ramlall T. F. Eliezer D. (2005) Helix periodicity, topology, and dynamics of membrane-associated alpha-synuclein. Protein Sci. 14, 862 872.
11. Carneiro A. M. Blakely R. D. (2006) Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. J. Biol. Chem. 281, 24769 24780.
12. Carneiro A. M., Ingram S. L., Beaulieu J. M. et al. (2002) The multiple LIM domain-containing adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter. J. Neurosci. 22, 7045 7054.
13. Charrier C., Bertrand P., Gesson J. P. et al. (2006) Cytoskeleton regulation of glycine receptor number at synapses and diffusion in the plasma membrane. J. Neurosci. 26, 8502 8511.
14. Clayton D. F. George J. M. (1998) The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21, 249 254.
15. Clayton D. F. George J. M. (1999) Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res. 58, 120 129.
16. Dipace C., Sung U., Binda F. et al. (2007) Amphetamine induces a calcium/calmodulin-dependent protein kinase II-dependent reduction in norepinephrine transporter surface expression linked to changes in syntaxin 1A/transporter complexes. Mol. Pharmacol. 71, 230 239.
17. Doussau F. Augustine G. J. (2000) The actin cytoskeleton and neurotransmitter release: an overview. Biochimie 82, 353 363.
18. Drenckhahn D. Kaiser H. W. (1983) Evidence for the concentreation of F-actin and myosin in synapses and in the plasmalemmal zone of axons. Eur. J. Cell Biol. 31, 235 240.
19. Eliezer D., Kutluay E., Bussell R. et al. (2001) Conformational properties of alpha-synuclein in its free and lipid-associated states. J. Mol. Biol. 307, 1061 1073.
20. Fifkova E. (1985) Actin in the nervous system. Brain Res. 356, 187 215.
21. Fountaine T. M. Wade-Martins R. (2007) RNA interference-mediated knockdown of alpha-synuclein protects human dopaminergic neuroblastoma cells from MPP(+) toxicity and reduces dopamine transport. J.Neurosci Res. 85, 351 363.
22. Frazer A. (2001) Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies. J. Clin. Psychiatry 62 (Suppl 12 16 23.
23. Galli A., DeFelice L. J., Duke B. J. et al. (1995) Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J. Exp. Biol. 198, 2197 2212.
24. Gesi M., Soldani P., Giorgi F. S. et al. (2000) The role of the locus coeruleus in the development of Parkinson's disease. Neurosci. Biobehav. Rev. 24, 655 668.
25. Goedert M. (2001) Alpha-synuclein and neurodegenerative diseases. Nat. Neurosci. Rev. 2, 492 501.
26. Goedert M., Spillantini M. G. Davies S. W. (1998) Filamentous nerve cell inclusions in neurodegenerative diseases. Curr. Opin. Neurobiol. 8, 619 632.
27. Goldman J. E. (1983) Immunocytochemical studies of actin localization in the central nervous system. J. Neurosci. 3, 1952 1962.
28. Head B. P., Patel H. H., Roth D. M. et al. (2006) Microtubules and actin filaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J. Biol. Chem. 281, 26391 26399.
29. Hebert C., Habimana A., Elie R. et al. (2001) Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: an autoradiographic study. Neurochem. Int. 38, 63 74.
30. Heikkila R. E., Orlansky H., Mytilineou C. et al. (1975) Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. J. Pharmacol. Exp. Ther. 194, 47 56.
31. Heldin C. H. (1995) Dimerization of cell surface receptors in signal transduction. Cell 80, 213 223.
32. Hirokawa N., Sobue K., Kanda K. et al. (1989) The cytoskeletal architecture of the presynaptic terminal and molecular structure of synapsin 1. J. Cell Biol. 108, 111 126.
33. Holton K. L., Loder M. K. Melikian M. E. (2005) Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nat. Neurosci. 8, 881 888.
34. Jayanthi L. D., Samuvel D. J. Ramamoorthy S. (2004) Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters. Evidence for localization in lipid rafts and lipid raft-mediated internalization. J. Biol. Chem. 279, 19315 19326.
35. Jayanthi L. D., Annamalai B., Samuvel D. J. et al. (2006) Phosphorylation of the norepinephrine transporter at threonine 258 and serine 259 is linked to protein kinase C-mediated transporter internalization. J. Biol. Chem. 281, 23326 23340.
36. Jeannotte A. M. Sidhu A. (2007) Regulation of the norepinephrine transporter by alpha-synuclein-mediated interactions with microtubules. Eur. J. Neurosci. 26, 1509 1520.
37. Jellinger K. A. (1991) Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol. Chem. Neuropathol. 14, 153 197.
38. Kantor L., Zhang M., Guptaroy B. et al. (2004) Repeated amphetamine couples norepinephrine transporter and calcium channel activities in PC12 cells. J. Pharmacol. Exp. Ther. 311, 1044 1051.
39. Kim C. H., Hahn M. K., Joung Y. et al. (2006) A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc. Natl Acad. Sci. USA 103, 19164 19169.
40. Kitayama T., Song L., Morita K. et al. (2006) Down-regulation of norepinephrine transporter function induced by chronic administration of desipramine linking to the alteration of sensitivity of local-anesthetics- induced convulsions and the counteraction by co-administration with local anesthetics. Brain Res. 1096, 97 103.
41. Klimek V., Stockmeier C., Overholser J. et al. (1997) Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J. Neurosci. 17, 8451 8458.
42. Kruger R., Kuhn W., Muller T. et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106 108.
43. Landis D. M., Hall A. K., Weinstein L. A. et al. (1988) The organization of cytoplasm at the presynaptic active zone of a central nervous system synapse. Neuron. 1, 201 209.
44. Lee F. J., Liu F., Pristupa Z. B. et al. (2001) Direct binding and functional coupling of alpha-synuclein to the dopamine transporters accelerat dopamine-induced apoptosis. FASEB J. 15, 916 926.
45. Lee H. J., Khoshaqhideh F., Lee S. et al. (2007) Impairment of microtubule-dependent trafficking by overexpression of alpha-synuclein. Eur. J. Neurosci. 24, 3153 3163.
46. Marien M. R., Colpaert F. C. Rosenquist A. C. (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res. Brain Res. Rev. 45, 38 78.
47. Mash D. C., Ouyang Q., Qin Y. et al. (2005) Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers. J. Neurosci. Methods 143, 79 85.
48. Masliah E., Rokenstein E., Veinbergs I. et al. (2000) Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265 1269.
49. Miller N. S. Gold M. S. (1993) A neurochemical basis for alcohol and other drug addiction. J. Psychoactive Drugs 25, 121 128.
50. Moussa C. E., Wersinger C., Rusnak M. et al. (2004) Abnormal migration of human wild-type alpha-synuclein upon gel electrophoresis. Neurosci. Lett. 371, 239 243.
51. Nestler E. J., Gould E., Manji H. et al. (2002a) Preclinical models: status of basic research in depression. Biol. Psychiatry 52, 503 528.
52. Nestler E. J., Barrot M., DiLeone R. J. et al. (2002b) Neurobiology of depression. Neuron 34, 13 25.
53. Pacholczyk T., Blakely R. D. Amara S. G. (1991) Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350 354.
54. Polymeropoulos M. H., Lavedan C., Leroy E. et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045 2047.
55. Ranscht B., Moss D. J. Thomas C. (1984) A neuronal surface glycoprotein associated with the cytoskeleton. J. Cell Biol. 99, 1803 1813.
56. Sontag J. M., Aunis D. Bader M. F. (1988) Peripheral actin filaments control calcium-mediated catecholamine release from streptolysin-O-permeabilized chromaffin cells. Eur. J. Cell Biol. 46, 316 326.
57. Spillantini M. G., Schmidt M. L., Lee V. M. et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839 840.
58. Sung U. Blakely R. D. (2007) Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A. Mol. Cell. Neurosci. 34, 251 260.
59. Trifaro J. M. Vitale M. L. (1993) Cytoskeleton dynamics during neurotransmitter release. Trends Neurosci. 16, 466 472.
60. Uchida J., Kiuchi Y., Ohno M. et al. (1998) Ca(2 +)-dependent enhancement of [3H]noradrenaline uptake in PC12 cells through calmodulin-dependent kinases. Brain Res. 809, 155 164.
61. Vitale M. L., Seward E. P. Trifaro J. M. (1995) Chromaffin cell cortical actin network dynamics control the size of the release-ready vesicle pool and the initial rate of exocytosis. Neuron. 14, 353 363.
62. Wersinger C. Sidhu A. (2003) Attenuation of dopamine transporter activity by alpha-synuclein. Neurosci. Lett. 340, 189 192.
63. Wersinger C. Sidhu A. (2005) Disruption of the interaction of alpha-synuclein with microtubules enhances cell surface recruitment of the dopamine transporter. Biochemistry 44, 13612 13624.
64. Wersinger C., Prou D., Vernier P. Sidhu A. (2003) Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J. 17, 2151 2153.
65. Wersinger C., Vernier P. Sidhu A. (2004) Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant. Biochemistry 43, 1242 1253.
66. Wersinger C., Jeannotte A. Sidhu A. (2006a) Attenuation of the norepinephrine transporter activity and trafficking via interactions with alpha-synuclein. Eur. J. Neurosci. 24, 3141 3152.
67. Wersinger C., Rusnak M. Sidhu A. (2006b) Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. Eur.J. Neurosci. 24, 55 64.
68. Xu F., Gainetdinov R. R., Wetsel W. C. et al. (2000) Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat. Neurosci. 3, 465 471.
69. Yang H. Raizada M. K. (1999) Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J. Neurosci. 19, 2413 2423.
70. Zahniser N. R. Doolen S. (2001) Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol. Ther. 92, 21 55.
71. Zarranz J. J., Alegre J., Gomez-Esteban J. C. et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164 173.
72. Zhu M. Y., Blakely R. D., Apparsundaram S. et al. (1998) Down-Regulation of the Human Norepinephrine Transporter in Intact 293-hNET Cells Exposed to Desipramine. J. Neurochem. 70, 1547 1555.